The overall goal of the RAPID (Rapid ART Program Initiative for HIV Diagnoses) program is to create a set of “hubs” around the city where persons newly diagnosed with HIV (or out of care) can rapidly access antiretroviral therapy (ART) and have a smooth transition to their medical home. In order to accomplish this goal, a RAPID steering committee established hub locations, standard operating procedure (SOP) for ART start, and SOP for transition to a primary medical home. The committee works with SF Department of Public Health surveillance (now “ARCHES”) to track the uptake and outcomes of persons participating in the program. We build on the existing LINCS programs at SFDPH to create and support hubs for rapid initiation of ART to individuals.
We start ART:
Within 48 hours –
- If acute/early infection (recent negative Ab test, RNA+/Ab– or recent symptoms of acute retroviral syndrome) or
- Evidence of advanced infection (opportunistic infection or a CD4 count of less than 200)
Within 5 days –
- All other newly HIV-diagnosed persons
The program aims to provide ART for up to 5 days for these individuals until they are transitioned into their medical home.
RAPID Resources
Publications
- *New* Outcomes of Rapid Restart Among People With Previously Diagnosed HIV at a Safety-Net HIV Clinic in San Francisco. JAIDS Journal of Acquired Immune Deficiency Syndromes 100(3):p 256-264, November 1, 2025.
- Development of a Citywide Rapid Antiretroviral Therapy Initiative in San Francisco. AJPM. 2021 November, Pages S47-S54.
- Decreased Time from HIV Diagnosis to Care, ART Initiation, and Virologic Suppression during the Citywide RAPID Initiative in San Francisco. CID. 2020 May 25.
- RAPID ART: High virologic suppression rates with immediate ART initiation in a vulnerable urban clinic population. AIDS. 2018 December 21.
News & Updates
Highlights from CROI 2023: A Report Back to the SF Community
Our local experts – Dr. Stephanie Cohen, Dr. Hyman Scott, Dr. Diane Havlir and Dr. Susan Buchbinder – presented updates on doxy-PEP, long-acting ART for prevention and treatment, Mpox, COVID and HIV vaccines. Here is a link to the recording – https://ucsf.box.com/s/8oz2otjgjsjkteyzp6cudd1mr6ffz4l2 – if you’d like to view/review the presentations. The audio only file is…
2022 World AIDS Day Consortium Meeting – PrEP, RAPID & Retention, DoxyPEP and drug overdose prevention in San Francisco
On World AIDS Day, we remember those we’ve lost to AIDS-related illness and reaffirm our support for those living with HIV. At this meeting, the GTZ-SF PrEP and RAPID/Restart & Retention committees presented their work plans to the community for input. GTZ-SF committees have been working to develop plans to address the challenges, gaps and…
New data, DoxyPEP and policy updates @ September 2022 Consortium Meeting
Thanks to Andy Scheer, SFDPH, and Laura Thomas, SF AIDS Foundation, for sharing critical policy updates. And thanks to Sharon Pipkin for presenting highlights from the latest HIV epidemiology report and to Dr. Monica Gandhi, Dr. Tyler TerMeer, Dr. Monique LaSarre and Dr. Hyman Scott for an engaging roundtable discussion reacting to the new data…
2022 Spring Consortium Meeting: The Tenderloin – voices from the field
The San Francisco Getting to Zero Consortium convened last Thursday, May 19th. The Co-Chairs of the GTZ-SF Steering Committee, Dr. Susan Buchbinder and Dr. Diane Havlir, shared committee updates and updates on emerging clinical topics. Senior Community Mobilization Manager with the SF AIDS Foundation, Ande Stone, then gave a presentation on the HIV Community Budget…